DMYD B — Diamyd Medical AB Balance Sheet
0.000.00%
- SEK1.45bn
- SEK1.22bn
- SEK0.13m
Annual balance sheet for Diamyd Medical AB, fiscal year end - August 31st, SEK millions except per share, conversion factor applied.
2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 139 | 160 | 128 | 132 | 277 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.65 | 2.44 | 4.67 | 4.02 | 4.09 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 163 | 173 | 141 | 159 | 292 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.55 | 45.7 | 52.3 | 49.4 | 52.7 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 201 | 237 | 206 | 217 | 353 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 11.4 | 21.4 | 19.9 | 40 | 27.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 12.2 | 22.1 | 36.4 | 71.1 | 72.6 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 189 | 214 | 169 | 146 | 280 |
Total Liabilities & Shareholders' Equity | 201 | 237 | 206 | 217 | 353 |
Total Common Shares Outstanding |